Regulatory effects of tea polysaccharides on hepatic inflammation, gut microbiota dysbiosis, and serum metabolomic signatures in beef cattle under heat stress
- PMID: 39308975
- PMCID: PMC11413490
- DOI: 10.3389/fphys.2024.1460414
Regulatory effects of tea polysaccharides on hepatic inflammation, gut microbiota dysbiosis, and serum metabolomic signatures in beef cattle under heat stress
Abstract
Background: Long-term heat stress (HS) severely restricts the growth performance of beef cattle and causes various health problems. The gut microbiota plays a crucial role in HS-associated inflammation and immune stress involving lymphocyte function. This study investigated the effects of dietary tea polysaccharide (TPS), a natural acidic glycoprotein, on HS-induced anorexia, inflammation, and gut microbiota dysbiosis in Simmental beef cattle.
Methods: The cattle were divided into two groups, receiving either normal chow or normal chow plus TPS (8 g/kg, 0.8%). Transcriptome sequencing analysis was used to analysis the differential signaling pathway of liver tissue. 16S rDNA sequencing was performed to analysis gut microbiota of beef cattle. Serum metabolite components were detected by untargeted metabolomics analysis.
Results: Hepatic transcriptomics analysis revealed that differentially expressed genes in TPS-fed cattle were primarily enriched in immune processes and lymphocyte activation. TPS administration significantly reduced the expression of the TLR4/NF-κB inflammatory signaling pathway, alleviating HS-induced hepatic inflammation. Gut microbiota analysis revealed that TPS improved intestinal homeostasis in HS-affected cattle by increasing bacterial diversity and increasing the relative abundances of Akkermansia and Alistipes while decreasing the Firmicutes-to-Bacteroidetes ratio and the abundance of Agathobacter. Liquid chromatography-tandem mass spectrometry (LC‒MS/MS) analysis indicated that TPS significantly increased the levels of long-chain fatty acids, including stearic acid, linolenic acid, arachidonic acid, and adrenic acid, in the serum of cattle.
Conclusion: These findings suggest that long-term consumption of tea polysaccharides can ameliorate heat stress-induced hepatic inflammation and gut microbiota dysbiosis in beef cattle, suggesting a possible liver-gut axis mechanism to mitigate heat stress.
Keywords: gut micobiota; inflammation; liver; long-chain fatty acids; tea polysaccharides.
Copyright © 2024 Li, Xu, Xie, Fei, Zhou, Li, Guang, Gong, Hu and Feng.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures






Similar articles
-
Regulatory Effects of Stachyose on Colonic and Hepatic Inflammation, Gut Microbiota Dysbiosis, and Peripheral CD4+ T Cell Distribution Abnormality in High-Fat Diet-Fed Mice.J Agric Food Chem. 2019 Oct 23;67(42):11665-11674. doi: 10.1021/acs.jafc.9b04731. Epub 2019 Oct 14. J Agric Food Chem. 2019. PMID: 31588753
-
Rumen-protected guanidinoacetic acid improves growth performance in beef cattle under chronic heat stress by reshaping gut microbiota and modulating serum metabolism.Front Microbiol. 2025 Feb 18;16:1529596. doi: 10.3389/fmicb.2025.1529596. eCollection 2025. Front Microbiol. 2025. PMID: 40041874 Free PMC article.
-
Heat stress-induced dysbiosis of the gut microbiota impairs spermatogenesis by regulating secondary bile acid metabolism in the gut.Sci Total Environ. 2024 Aug 10;937:173305. doi: 10.1016/j.scitotenv.2024.173305. Epub 2024 May 20. Sci Total Environ. 2024. PMID: 38777056
-
Gardenia jasminoides Ellis polysaccharide ameliorates cholestatic liver injury by alleviating gut microbiota dysbiosis and inhibiting the TLR4/NF-κB signaling pathway.Int J Biol Macromol. 2022 Apr 30;205:23-36. doi: 10.1016/j.ijbiomac.2022.02.056. Epub 2022 Feb 14. Int J Biol Macromol. 2022. PMID: 35176320
-
Improvement of chronic metabolic inflammation and regulation of gut homeostasis: Tea as a potential therapy.Pharmacol Ther. 2025 May;269:108828. doi: 10.1016/j.pharmthera.2025.108828. Epub 2025 Feb 26. Pharmacol Ther. 2025. PMID: 40020787 Review.
References
LinkOut - more resources
Full Text Sources